INTRODUCTION
transport model for synthetic TAT peptide, has been questioned in several recent studies (17) (18) (19) . It has been shown that apparent ATP and temperature independence of the cellular uptake of the TAT peptide, as well as its fast nuclear accumulation, results from experimental artifacts due to cell fixation and incomplete removal of cell bound peptide (18, 19) . Recently the uptake of TAT and (Arg) 9 peptides has been attributed to a vesiculation process inhibited by cellular ATP depletion and by low temperature (19) .
While several very recent papers provide additional evidence for the involvement of endocytic pathways in the transduction of PTD's alone as well as PTD's conjugated to a cargo (20) (21) (22) (23) , the alternative mechanism of direct translocation has been also argued for in the recent literature (24, 25) .
In the present work we further clarify the mechanisms by which TAT peptide enters living cells. As in the case of the stable cell lines used in our earlier work, TAT entry into several different primary cells is found to be ATP-and temperaturedependent indicating the involvement of endocytosis. Judging from the effects of specific inhibitors, unconjugated TAT peptide enters cells mainly by a clathrindependent endocytic pathway, while raft/caveolin-dependent pathway is not required for internalization. While a significant part of TAT peptide uptake involves heparan sulfate receptors, these receptors are not a pre-requisite for TAT entry. cultured as exponentially growing subconfluent monolayers on 90-mm plates in endothelial cell basal medium (EBM) (Clonetics) supplemented with 2% (v/v) fetal calf serum and 2 mM glutamine, Hydrocortisone 1mg/ml, Gentamicin 50µg/ml, Amphotericin B 50pg/ml, Bovine brain extract 0.75µg/ml and recombinant human epidermal growth factor 10µg/ml. Peripheral blood, obtained from healthy donors, was collected in heparinized tubes. The peripheral blood mononuclear cells (PBMC) were separated by Ficoll-Hypaque (Sigma) as described previously (26) . Flow cytometry. In the case of HeLa, HepG2 and human macrophages exponentially growing cells were dissociated with a nonenzymatic cell dissociation medium (Sigma). 5x10 5 cells were plated and cultured overnight on 30-mm dishes. The culture medium was discarded, and cells were washed with NaCl/P i (pH 7.3). NaCl/P i was discarded, and cell monolayers were preincubated with Opti-MEM during 30 min. Subsequently, the cell monolayers were incubated, as described below, with peptides and drugs dissolved in Opti-MEM. Following incubation, cells were washed with NaCl/P i and incubated 10 min with 0.1% trypsin (except HUVEC which were treated with 0.05% trypsin) to detach them and to remove surface-bound material. In some experiments membranebound peptides were removed by 15 min incubation at 4°C with 0.1% pronase and 1mM EDTA. After the incubation, one volume of serum was added to stop the trypsin (or pronase) treatment and 10 volumes of NaCl/P i were added to detach completely the cells. The cell suspension was centrifuged at 800g, washed with NaCl/P i, centrifuged again, and resuspended in 500µl of NaCl/P i .
In case of wild type and mutant CHO cells, exponentially growing cells were dissociated with a nonenzymatic cell dissociation medium and resuspended in serumfree Ham's F12K medium. Subsequently, 5x10 5 cells were incubated, as described in the figure legends, with 200µl of TAT peptide dissolved in F12K medium. Following incubation, cell suspension was centrifuged at 800g, washed twice with 2ml of cold NaCl/P i and incubated 10 min with 200µl of 0.1% trypsin to remove surface-bound peptide. Finally cells were washed once with 2ml F12K medium supplemented with 10% fetal calf serum and once with 2ml of cold NaCl/P i and resuspended in 500µl of NaCl/P i , containing 10µM propidium iodide (Molecular Probes) to exclude dead cells. Significance of the effects of various treatments as compared to untreated control was evaluated by paired t-test at the 95% confidence level.
RESULTS
studied the effects of ATP depletion and low temperature on TAT peptide uptake by human PBMC macrophages and HUVEC endothelial cells. The primary cells were incubated with AlexaFluor488-tagged TAT peptide for 30 min and the amount of internalized peptide was evaluated using FACS. As shown on Fig. 1 , TAT uptake was greatly inhibited at 4°C in both tested cell types. When cells were pre-incubated with sodium azide and deoxyglucose to deplete the cellular ATP pool, a smaller but still significant inhibition of TAT uptake was observed (Fig. 1) . Temperature-and ATPdependence of TAT uptake by the primary cells suggest that entry by endocytosis is a general mechanism of TAT internalization valid for primary cells rather than a mechanism characteristic only for established cell lines. (Fig 2A,B) . However a significant amount of peptide was internalized even in the absence of heparan sulfate receptors ( Fig. 2A) . In control experiments no decrease in uptake of the lypophilic dye FM 4-64, a heparan sulfate independent marker of endocytosis, was observed in both mutant cell lines in comparison with wild type cells (Fig. 2B) . The involvement of heparan sulfate receptors in TAT peptide was confirmed with another experimental approach. The pre-treatment of cells with heparinase III inhibited TAT uptake in wild type cells, but not in heparan sulfate receptor-deficient cells (Fig. 2C,D) . While these data indicate the importance of heparan sulfate receptors for the uptake of TAT peptide in wild type CHO cells, Fig. 2 also shows TAT internalization in the absence of heparan sulfate proteoglycans, indicating the existence of heparan sulfate independent mechanisms of entry.
TAT peptide uptake involves caveolin-independent pathways of endocytosis.
The uptake of TAT peptide fused to proteins has been recently attributed specifically to caveolin-dependent pathway (21, 22) . In contrast, in our earlier work (19) efficient uptake of unconjugated TAT peptide was observed in a number of cell lines, deficient in caveolin-1 expression, including Jurkat T cell line and HeLa cells (27) . Likewise, we observed an ATP-and temperature-sensitive uptake of TAT in HepG2 hepatoma cells (data not shown), which have been reported to lack caveolin-1 (28) . To specifically test whether internalization of free TAT peptide involves caveolin-dependent endocytosis we explored the effects of nystatin and filipin III -both known inhibitors of caveolin dependent uptake (29). Both inhibitors had little effect on the uptake of AlexaFluor488-tagged TAT peptide in HeLa cells (data not shown). That is not surprising considering the low level of caveolin-1 expression in these cells and the inefficient internalization of a well-established marker of raft/caveolin-dependent endocytic pathway, BODIPY-lactosylceramide (BODIPY-LacCer) (27) . Importantly, in CHO cells, which efficiently express caveolin-1 and actively internalize BODIPY-LacCer by guest on http://www.jbc.org/ Downloaded from (27) , uptake of AlexaFluor488-tagged TAT peptide incubation also was not significantly affected in the presence of 50 µg/ml nystatin (Fig. 3A, D) , while in the same conditions uptake of BODIPY-LacCer was inhibited by ~30% (Fig. 3B, D) . As expected, nystatin had no effect on uptake of Fluorescein-tagged transferrin (Fig. 3C, D) . Taken together these results indicate that cellular uptake of unconjugated TAT peptide does not require raft/caveolin-dependent endocytic pathway.
Cellular uptake of TAT peptide involves clathrin-dependent endocytosis. To test
whether TAT uptake involves clathrin coated pit mediated endocytosis, TAT uptake was measured in the presence of known inhibitors of this endocytic pathway, potassium depletion and chlorpromazine. Treatment of HeLa cells with chlorpromazine (30-min preincubation in the presence of 30µM chlorpromazine followed by 30-min incubation with both 30µM chlorpromazine and 1µM AlexaFluor488-tagged TAT peptide) resulted in 50% inhibition of peptide uptake (Fig. 4A, C) . Similarly, 30-min preincubation of HeLa cells in potassium-free buffer followed by 5-min hypotonic shock and 30-min incubation with 1µM AlexaFluor488-tagged TAT peptide in potassium free buffer resulted in 40% decrease in peptide uptake (Fig. 4B, C) . In control experiments significant inhibition was observed for the uptake of fluorescently labeled transferrin, a well-established marker of clathrin-dependent endocytosis (Fig. 4C) .
Inhibition of the uptake of AlexaFluor488-tagged TAT peptide and fluorescein-tagged transferrin in potassium-free buffer was completely reversible upon replenishment of potassium in the media (Fig. 4B, C) . These data indicate that in the absence of active caveolin-dependent endocytosis TAT peptide is efficiently internalized by clathrindependent endocytic pathway.
To test involvement of clathrin-dependent pathway in cells efficiently expressing caveolin-1 we explored the effect of potassium depletion on the TAT peptide uptake in CHO cells, which efficiently express caveolin-1 (27) . Cellular internalization of AlexaFluor488-tagged TAT peptide (Fig. 5A, C) was inhibited by ~55% in potassiumfree buffer as compared to ~85% inhibition of Fluorescein-tagged transferrin uptake (Fig. 5B, C) . Again, as with HeLa cells inhibition for both AlexaFluor488-tagged TAT peptide and fluorescein-tagged transferrin was completely reversible upon replenishment of potassium in the media (Fig. 5) . These data indicate that even in cells efficiently expressing caveolin-1 uptake of unconjugated TAT peptide involves clathrindependent pathway of endocytosis.
Internalized TAT peptide is targeted to acidic compartments. As endocytosed proteins pass from early to late endosomes and to lysosomes, the vesicular compartments undergo progressive acidification. Even early endosomes show a reduction in pH (5.9-6.0) to promote the release of ligands bound to receptors.
Acidification of these luminal compartments is blocked by agents such as monensin (30) . To test whether endocytosed TAT peptide is targeted into acidified compartments, we took advantage of the fact that the fluorescence of fluorescein significantly decreases at pH=5-6 typical for endosomes and lysosomes as compared to fluorescence at pH=7.4 of cell culture media. We incubated HeLa cells with 2µM fluorescein-tagged TAT for 60 min followed by 30 min incubation in the presence or in the absence of 50µM monensin was not affected by monensin (Fig. 6A,C) . These experiments indicate that a significant fraction of the TAT peptide is delivered into acidic cellular compartments.
DISCUSSION
While the number of publications confirming the great potential of PTD's for cellular delivery of many important compounds is increasing each year (1), the mechanism of PTD-mediated delivery, remains elusive. For about a decade it was commonly accepted that despite their highly polar nature PTD's are able to rapidly and efficiently translocate directly through the lipid bilayer, thus delivering their cargo into the cytoplasm and nucleus in a receptor-and energy-independent way (14, 15) . This model was supported by a large number of indirect evidences, including temperature-, ATP-and receptor independence of cellular uptake (11) (12) (13) (14) , but attempts to directly validate this model on protein-free lipid bilayer systems gave contradictory results (31, 32) . Moreover, it was recently shown, that apparent ATP-and temperatureindependence as well as fast kinetics of PTD's uptake result from artifacts of cell by guest on http://www.jbc.org/ Downloaded from fixation and incomplete removal of surface-bound peptide (18, 19) . These recent findings have led to a major reevaluation of key characteristics of PTD's internalization and the role of endocytosis in PTD mediated uptake.
Our present results indicate that fluorescently labeled TAT peptide, as full-length TAT protein (16) or TAT-streptavidin conjugate (20) , uses heparan sulfate receptors for internalization. However, the uptake of small basic peptides such as the TAT PTD might be also mediated by other pathways as suggested by the fact that the internalization of TAT peptide is not completely inhibited in cells lacking surface heparan sulfates due to mutations or enzymatic treatment. The observed promiscuity of TAT peptide in terms of receptor use is not very surprising given the highly cationic nature of the peptide and the abundance of negatively charged moieties on the cell surface. Therefore one might expect that in addition to specific interactions with heparan sulfate proteoglycans there may well be a high level of electrostatic interactions with other negatively charged cell surface determinants. The importance of cell surface receptors for TAT uptake, mentioned above, as well as ATP-and temperaturedependence, as shown in this and earlier works (18, 19) , demonstrate that TAT peptide uptake involves endocytosis. In some of the recent reports arguing for the crucial role of endocytosis in the uptake of constructs in which the TAT peptide was fused to proteins, the uptake has been attributed specifically to caveolae-dependent pathway (21, 22) . On the other hand, we found cells deficient in caveolin-1 expression or lacking caveolin-1 cells to be able to efficiently internalize unconjugated TAT peptide. This indicates that caveolin-dependent pathway is not required for TAT peptide uptake and alternative pathways might be utilized for uptake of TAT in those cells. We therefore tested the effects of various inhibitors of clathrin-and caveolae-dependent endocytosis on the uptake of unconjugated TAT peptide. For both caveolin-1 expressing and caveolin-1 deficient cells inhibitors of clathrin-dependent pathway (potassium depletion and chlorpromazine) significantly decrease TAT peptide uptake, while inhibitors of raft/caveolin-dependent pathway (nystatin and filippin III) have no significant effect on the uptake. These findings support an involvement of endocytosis in the TAT internalization and show that clathrin-dependent pathway is involved in cellular uptake of unconjugated TAT, while raft/caveolin-dependent pathway does not play a significant role. Along the same lines, the full-size TAT protein is internalized by a clathrin-dependent pathway (33) . In contrast to our results, recent reports on the cellular uptake of TAT peptide conjugated to proteins in HeLa and CHO cells have attributed uptake of these conjugates to caveolin-dependent pathway (21, 22) . This apparent discrepancy suggests that free TAT peptide and TAT peptide conjugated to macromolecules utilize different pathways for internalization, possibly due to difference in receptor usage. Interestingly, recent report on the uptake of TAT conjugated to Cre recombinase in T cells, which are deficient in caveolin-1, implicates caveolin-independent lipid raft macropinocytosis in transduction of TAT-Cre recombinase into cells (34) . Very recently lipid raft macropinocytosis also has been implicated in the uptake of unconjugated TAT peptide (35) . However methyl-β-cyclodextrin, which was used in this work to inhibit raft/caveolin dependent pathway, has been shown to affect clathrin-dependent pathway (36), thus complicating interpretation of the data. Taken together these data indicate that alternative pathways could be used for TAT uptake depending on cell type and nature (and presence) of conjugated cargo. It is possible, that while free fluorescently labeled TAT peptide is mainly directed into constitutive clathrin-dependent pathway, and TAT peptide conjugated to macromolecular cargo upon binding to cellular receptors induces signaling cascades activating caveolin-dependent endocytosis or macropinocytosis.
Whatever the case, our results confirm that endocytosis is a major route of TAT peptide internalization. It is generally accepted that endocytosed material is targeted to late endosomes or lysosomes -compartments that contain active proteases and are involved in the degradation of internalized proteins and other macromolecules. In our experiments with monensin -an inhibitor of endosome acidification, we found that within 1h at least a part of the TAT peptide is delivered into acidic compartments.
Trapping and possible degradation of TAT peptides within these acidic vesicles is at odds with effective delivery of bioactive transported cargo within cytoplasm and/or nucleus. Nevertheless the delivery of functionally active proteins into the cytoplasm and the nucleus (7,9,10) has been well documented. This apparent discrepancy could be explained by different sensitivities of the experimental approaches. While in our experiments we measure the total amount of internalized peptide, the delivery of only a negligible fraction of total TAT conjugate to the cytoplasm or to the nucleus might be sufficient for functional detection of the transduction with very sensitive biological assays as an end-point. It is possible therefore that only a small fraction of all There are several hypothetical mechanisms by which PTDs can facilitate transduction of macromolecules into the cell. First, it is possible that once inside endosomes, TAT and other cationic PTD's destabilize the endosomal membrane to leak a portion of the enclosed macromolecules into the cytoplasm as reported for polyethyleneimine (37) . TAT-induced destabilization of endosomes might involve TAT interactions with proteins or lipids specific to endosomal compartments. These interactions can be promoted by acidic pH inside endosomes. It is also possible that a functionally relevant fraction of the TAT peptide utilizes the caveolin-dependent endocytic pathway that bypasses acidic cellular compartments. This pathway is used by some viruses as recently described for SV 40 (38) . Finally, one cannot exclude the possibility that a small, but nonetheless all-important, fraction of the TAT peptide directly crosses the lipid bilayer to deliver conjugated cargo into the cytoplasm. This latter mechanism was additionally supported by the recent study, demonstrating direct translocation of penetratin (another well studied PTD) through protein-free synthetic lipid bilayers (39) . Translocation of penetratin was shown to be lipid composition dependent, requiring the presence of anionic lipids and high (>100mV) transmembrane potentials and was observed in a much slower time frame than previously expected (several hours rather than minutes) (39) . This slow direct translocation of PTD through membranes might be of importance for the release of PTD from endosomes and lysosomes into the cytosol.
To conclude, our experiments further substantiate the key role of endocytosis in the PTD entry into living cells and provide new insights into utilized endocytic pathways and surface receptors. We believe that these results along with future work involving sensitive functional assays will bring a better understanding of the mechanisms by which relatively short PTD deliver large cargos to the cytosol and nucleus. After incubation cells were washed with NaCl/P i , and treated with trypsin.
